Nukkleus Inc. Just Filed Its Quarterly Report: Per share data ASC T...

Per share data

 

ASC Topic 260, Earnings per Share, requires
presentation of both basic and diluted earnings per share (“EPS”) with a reconciliation of the numerator and denominator of
the basic EPS computation to the numerator and denominator of the diluted EPS computation. Basic EPS excludes dilution. Diluted EPS reflects
the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted i nto common
stock or resulted in the issuance of common stock that then shared in the earnings of the entity.

 

Basic net earnings per share are computed
by dividing net earnings available to common stockholders by the weighted average number of shares of common stock outstanding during
the period. Diluted net earnings per share is computed by dividing net earnings applicable to common stockholders by the weighted average
number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during each period. Diluted
earnings per share reflects the potential dilution that could occur if securities were exercised or converted into common stock or other
contracts to issue common stock resulting in the issuance of common stock that would then share in the Company’s earnings subject
to anti-dilution limitations. In a period in which the Company has a net loss, all potentially dilutive securities are excluded from the
computation of diluted shares outstanding as they would have an anti-dilutive impact. For the three
and nine months ended June 30, 2021 and 2021, potentially dilutive common shares consist of common stock issuable upon the conversion
of Series A preferred stock (using the if-converted method).

 

The following is a reconciliation of the basic
and diluted net (loss) income per share computations for the three and nine months ended June 30, 2021 and 2020:

 

Basic net (loss) income
per share

 
































   Three Months Ended
June 30,

2021
   Three Months Ended
June 30,

2020
   Nine Months
Ended
June 30,

2021
   Nine Months Ended
June 30,

2020
 
Net (loss) income available to Nukkleus Inc. for basic net (loss) income per share of common stock  $(103,804)  $11,492   $(157,350)  $(97,659)
Weighted average common stock outstanding - basic   257,055,897    230,485,100    239,342,032    230,485,100 
Net (loss) income per common share attributable to Nukkleus Inc.:                    
Basic  $(0.00)  $0.00   $(0.00)  $(0.00)

 

Diluted net (loss)
income per share

 




































































   Three Months Ended
June 30,

2021
   Three Months Ended
June 30,

2020
   Nine Months
Ended
June 30,

2021
   Nine Months Ended
June 30,

2020
 
Net (loss) income available to Nukkleus Inc. for basic net (loss) income per share of common stock  $(103,804)  $11,492   $(157,350)  $(97,659)
Add: interest expense for redeemable preferred stock   -    938    -    - 
Subtract: unamortized debt discount for redeemable preferred stock   -    (2,118)   -    - 
Net (loss) income available to Nukkleus Inc. for diluted net (loss) income per share of common stock  $(103,804)  $10,312   $(157,350)  $(97,659)
Weighted average common stock outstanding - basic   257,055,897    230,485,100    239,342,032    230,485,100 
Effect of dilutive securities:                    
Series A preferred stock   -    1,250,000    -    - 
Weighted average common stock outstanding - diluted   257,055,897    231,735,100    239,342,032    230,485,100 
Net (loss) income per common share attributable to Nukkleus Inc.:                    
Diluted  $(0.00)  $0.00   $(0.00)  $(0.00)

 

For the three and nine months ended June 30, 2021
and for the nine months ended June 30, 2020, a total of 1,250,000 shares of common stock from the assumed redemption of the Series A convertible
redeemable preferred stock at the contractual floor of $0.20 per share have been excluded from the computation of diluted weighted average
number of shares of common stock outstanding as they would have had an anti-dilutive impact.

 

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Nukkleus Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

Nukkleus Inc. Just Filed Its Quarterly Report: Per share data ASC T... - Aug. 1, 2022
Nukkleus Inc. Just Filed Its Quarterly Report: Per share data ASC T... - Aug. 1, 2022
Change in Registrants Certifying - July 29, 2022
Nukkleus Inc. Just Filed Its Annual Report: Per share data ASC T... - July 27, 2022

Auto Refresh

Feedback